These success, along with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 aid the concept of focusing on ACKR3 as a novel solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked Problem